Objective: Methergine increases constriction of uterine musculature which may facilitate sloughing of endometrial debris, close uterine vessels, and prevent post-cesarean endometritis. The objective of this study was to evaluate the efficacy of methergine in preventing endometritis in patients undergoing non-elective cesarean section delivery.
major complication of cesarean section is post-,operative endometritis. The incidence of this in non-elective cesarean sections is reported to be from 12% to 95%, depending upon patient population and the indications for surgery. In the methergine group there were ten patients with an arrest disorder of labor compared to twenty-one in the control group (P < 0.01). Intrauterine pressure catheters were used frequently to diagnose and treat this disorder. They were used in twelve patients in the methergine treated group compared to twenty-three in the control group (P The present prospective randomized study utilized a patient population at high risk for developing postpartum endometritis, namely non-elective cesarean section patients. The results demonstrated that the methergine treated group had a significantly reduced rate of endometritis (10% vs. 36%) and a higher postoperative hemoglobin level.
Methergine causes uterine contraction that constricts blood vessels and reduces blood loss. Methergine may then result in a decrease in endometritis by facilitating uterine involution and expulsion of uterine decidua, thereby limiting the nidus for bacterial growth. In this small sample, there were no adverse side effects from methergine as determined by no withdrawal due to side effects.
In conclusion, methergine is safe, inexpensive, and effective in preventing postoperative endometritis and blood loss in non-elective cesarean section patients. Its routine use postoperatively should be seriously considered if no contraindications exist.
